Central Retinal Vein Occlusion in the Absence of Conventional Risk Factors Associated With Breast Carcinoma: A Case Report.

Central retinal vein occlusion in 41-year-old female patients without conventional risk factors should raise concern for systemic evaluation for underlying malignancy and treatment-related hypercoagulability. Breast carcinoma and chemotherapy (e.g., capecitabine) may represent plausible contributing factors. Early recognition with intravitreal anti-vascular endothelial growth factor therapy can significantly improve visual outcomes.